日本はCIRDにVYVDURAを承認し,家庭注射によるまれな神経障害の治療に先行する. Japan approves VYVDURA for CIDP, a first for treating the rare nerve disorder with home injections.

日本では,VYVDURAが,希少な神経疾患であるCIDPの成人の治療に承認されています. Japan has approved VYVDURA for treating adults with CIDP, a rare nerve disorder. CIDPで初めての新生児 FC受容体遮断器で 週に1回の注射を承認する It's the first neonatal Fc receptor blocker for CIDP, approved for self-administered weekly injections at home. この承認は,再発のリスクを66%削減する研究に基づき,日本がこの薬の3つの兆候を備えた最初の国となる. This approval, based on a study showing a 61% reduction in relapse risk, makes Japan the first country with access to three indications for this drug.